At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Speech Entrainment for Aphasia Recovery
In Brief
A Phase 2 clinical trial evaluating SET (Speech Entrainment Therapy) 3 weeks, SET (Speech Entrainment Therapy) 4.5 weeks, and 2 other interventions for Aphasia and 2 related conditions. Completed, enrolled 80 participants across 3 sites.
Detailed Summary
After a stroke, many people experience a language impairment called aphasia. One of the most debilitating types of aphasia is non-fluent aphasia. Non-fluent aphasia is defined by significantly reduced speech production, with the speaker producing only a few words or even less. Speech entrainment therapy (SET) is a treatment that has been shown to increase fluency in people with non-fluent aphasia. The study looks to define the best dose of SET that leads to sustained improvements in spontaneous speech production. Participants who are eligible will undergo baseline language testing, an MRI, and will be randomized into one of 4 treatment groups: SET for 3 weeks, SET for 4.5 weeks, SET for 6 weeks, and no treatment (control group).
Study Details
Timeline
Interventions
3 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
4.5 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
6 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program
Participants will not be getting any SET for 6 weeks